1. H1N1 Vaccine Market – Overview
1.1 Definitions and Scope
2. H1N1 Vaccine Market – Executive Summary
2.1 Market Revenue and Key Trends by Company
2.2 Key trends by Vaccine Type
2.3 Key trends by Type of Brand
2.4 Key trends by Geography
3. H1N1 Vaccine Market – Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split by Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis
4. H1N1 Vaccine Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters five force model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. H1N1 Vaccine Market – Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. H1N1 Vaccine Market – By Vaccine Type (Market Size –$Million/$Billion)
6.1 Intranasal
6.2 Conjugate
6.3 Attenuated Vaccines
6.4 Inactivated Vaccine
6.5 Intramuscular
6.6 Toxoid
6.7 Others
7. H1N1 Vaccine Market – By Type of Brand (Market Size –$Million/$Billion)
7.1 Agripal
7.2 Fiuarix
7.3 Influgen
7.4 Influvac
7.5 Nasovac
7.6 Vaxigrip
7.7 Other
8. H1N1 Vaccine Market – By Geography
8.1 North America
8.1.1 U.S.
8.1.2 Mexico
8.1.3 Canada
8.2 Europe
8.2.1 U.K.
8.2.2 France
8.2.3 Germany
8.2.4 Italy
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 China
8.3.2 India
8.3.3 Japan
8.3.4 South Korea
8.3.5 Australia
8.3.6 New Zealand
8.3.7 Rest of APAC
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Africa
8.4.3 South America
9. H1N1 Vaccine Market – Entropy
10. H1N1 Vaccine Market Company Analysis
10.1 Company 1
10.2 Company 2
10.3 Company 3
10.4 Company 4
10.5 Company 5
10.6 Company 6
10.7 Company 7
10.8 Company 8
10.9 Company 9
10.10 Company 10
“*Financials for private companies would be provided on a best efforts basis”.
Report Description
Overview
H1N1 백신 시장은 계절성 독감 및 팬데믹 예방을 위한 예방 접종용 백신으로 구성됩니다.
Segment
주요 세그먼트는 백신 유형(비활성화 백신, 생백신 등)과 브랜드(Agripal, Fluarix 등), 지리적 구분(북미, 유럽, 아시아 태평양 등)으로 나뉩니다. 특히 정부 주도의 백신 접종 캠페인과 공공 보건 정책이 시장 성장을 주도하고 있습니다.
Key Takeaways
H1N1 백신 시장은 감염병 예방에 대한 인식 확산과 함께 성장이 지속되고 있으며, 기술 혁신과 정부 지원이 주요 동력으로 작용하고 있습니다.
